Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025

                    Revenue
                    FY2025
                
$6.9B
                    3y CAGR +0.5%
                    
                    P17
                    
                    n/a
                    
                    Net income
                    FY2025
                
$1.3B
                    Net margin +18.8%
                    
                    P77
                    
                    n/a
                    
                    Total assets
                    FY2025
                
$12.7B
                    ROA +10.2%
                    
                    P72
                    
                    n/a
                    
                    Operating cash flow
                    FY2025
                
$1.6B
                    FCF margin +16.6%
                    
                    P55
                    
                    n/a

20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s total assets.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 1 year

Total assets $12.7B

Total liabilities $6.0B

Shareholders equity $6.7B

Account	2025	Trend
Assets
Cash and Cash Equivalents	14.1%
Short Term Investments	0.0%
Accounts Receivable	11.7%
Inventory	8.1%
Prepaid Expenses	2.3%
Other Current Assets	2.3%
Total Current Assets	36.1%
Property,Plant and Equipment	15.9%
Operating Lease Assets	1.4%
Goodwill	35.1%
Intangible Assets	3.5%
Long Term Investments	1.0%
Other Noncurrent Assets	8.3%
Total Assets	100.0%
Liabilities
Accounts Payable	4.5%
Accrued Liabilities	3.5%
Deferred Revenue	4.9%
Current Portion of Long Term Debt	2.4%
Total Current Liabilities	18.4%
Long Term Debt	24.0%
Deferred Revenue Noncurrent	4.9%
Other Noncurrent Liabilities	3.6%
Total Liabilities	47.0%
Equity
Preferred Stock	0.0%
Common Stock	0.0%
Additional Paid In Capital	43.8%
Retained Earnings	10.9%
Treasury Stock	0.0%
Accumulated Other Comprehensive Income	-1.8%
Total Stockholders Equity	53.0%
Total Liabilitiesand Equity	100.0%

Income Statement

Revenue, expense, and profitability

20 accounts · 1 year

Revenue $6.9B

Operating income $1.5B

Net income $1.3B

Account	2025	Trend
IncomeStatement
Revenues Total Revenue	54.6%
Expenses Cost of Revenue	26.0%
Expenses Research and Development	3.6%
Expenses Selling,General and Administrative	13.4%
Expenses Depreciation and Amortization	2.3%
Expenses Share Based Compensation	1.0%
Expenses Restructuring and Asset Impairment	0.6%
Expenses Operating Expenses	43.0%
Other Income Expense Operating Income	11.6%
Other Income Expense Interest Income	0.5%
Other Income Expense Interest Expense	0.9%
Other Income Expense Other Income/expense	0.0%
Other Income Expense Income Before Tax	11.3%
Income Tax Income Tax Expense	1.0%
net Income net Income	10.2%
net Income Comprehensive Income	10.9%
Earnings Per Share Basic Eps	0.0%
Earnings Per Share Diluted Eps	0.0%
Earnings Per Share Weighted Average Shares Basic	2.2%
Earnings Per Share Weighted Average Shares Diluted	2.2%

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 1 year

Operating cash flow $1.6B

Investing cash flow $-394.0M

Financing cash flow $-715.0M

Account	2025	Trend
CashFlow
Operating Activities net Income	10.2%
Operating Activities Depreciation and Amortization	2.3%
Operating Activities Stock Based Compensation	1.0%
Operating Activities Deferred Income Taxes	-1.0%
Operating Activities Changes In Operating Assets and Liabilities	6.5%
Operating Activities net Cash From Operating Activities	12.2%
Investing Activities Capital Expenditures	3.2%
Investing Activities Business Acquisitions	-0.0%
Investing Activities Purchases of Investments	0.0%
Investing Activities net Cash From Investing Activities	-3.1%
Financing Activities Proceeds From Debt	0.0%
Financing Activities Repayment of Debt	0.0%
Financing Activities Repurchase of Common Stock	3.3%
Financing Activities Dividends Paid	2.2%
Financing Activities Proceeds From Stock Issuance	0.6%
Financing Activities Tax Withholding On Stock Based Compensation	0.2%
Financing Activities Other Financing Activities	0.0%
Financing Activities net Cash From Financing Activities	-5.6%
Cash Reconciliation Effect of Exchange Rate On Cash	0.1%
Cash Reconciliation net Change In Cash	3.6%
Cash Reconciliation Cash At Beginning of Period	14.1%
Cash Reconciliation Cash At End of Period	14.1%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year

Ratio	2025
Profitability
Gross margin	+52.4%
Operating margin	+21.3%
Net margin	+18.8%
FCF margin	+16.6%
Growth
Revenue CAGR (3y)	+0.5%
Returns
ROE	+19.3%
ROA	+10.2%
ROIC	+16.2%
Liquidity
Current ratio	1.96x
Quick ratio	1.40x
Leverage
D/E	0.89x
Interest coverage	13.21x
Efficiency
Asset turnover	0.55x
Cash conversion cycle	+128d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 166d old · FY2025

Market cap $32.9B

P/E 25.26x

P/S 4.74x

P/B 4.88x

EV $34.5B

EV/EBITDA 19.51x

FCF yield +3.5%

Dividend yield +0.9%

Notes

Your annotations

Not watched